ClearideBio Therapeutics, founded in December 2025, develops antibody-drug conjugates against solid tumours. The Japanese CVC arm of LOTTE HOLDINGS is leading its pre-seed round, of undisclosed size.
- Announced on
- Round
- Pre-seed
- Amount
- Amount not disclosed
- Location
- Basel, canton of Basel-Stadt
- Sector
- Biotech & life sciences
Investors
- LOTTE HOLDINGDS Healthcare & Biopharmaceutical CVC lead
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic